<div id="readability-page-1"><div><p>As the U.S. stock market reaches new highs with the S&amp;P 500 closing at a record level and tech stocks leading recent gains, investors are closely watching high-growth sectors for potential opportunities. In this environment, identifying strong tech stocks involves considering their capacity for innovation and resilience amid evolving economic conditions.</p><h3>Top 10 High Growth Tech Companies In The United States</h3><table><tbody><tr><th>Name</th><th>Revenue Growth</th><th>Earnings Growth</th><th>Growth Rating</th></tr><tr><td>Marker Therapeutics</td><td>75.24%</td><td>59.07%</td><td>★★★★★★</td></tr><tr><td>Palantir Technologies</td><td>28.00%</td><td>32.57%</td><td>★★★★★★</td></tr><tr><td>Workday</td><td>11.13%</td><td>32.18%</td><td>★★★★★☆</td></tr><tr><td>Circle Internet Group</td><td>23.08%</td><td>84.58%</td><td>★★★★★☆</td></tr><tr><td>HubSpot</td><td>14.28%</td><td>48.34%</td><td>★★★★★☆</td></tr><tr><td>RenovoRx</td><td>71.45%</td><td>71.45%</td><td>★★★★★☆</td></tr><tr><td>Zscaler</td><td>15.85%</td><td>45.93%</td><td>★★★★★☆</td></tr><tr><td>Precigen</td><td>55.77%</td><td>79.70%</td><td>★★★★★☆</td></tr><tr><td>Procore Technologies</td><td>11.70%</td><td>116.48%</td><td>★★★★★☆</td></tr><tr><td>Duos Technologies Group</td><td>53.36%</td><td>152.11%</td><td>★★★★★☆</td></tr></tbody></table><p>Click here to see the full list of 73 stocks from our US High Growth Tech and AI Stocks screener.</p><p>Let's dive into some prime choices out of from the screener.</p><h2>Viant Technology (DSP)</h2><p><strong>Simply Wall St Growth Rating:</strong> ★★★★☆☆</p><p><strong>Overview:</strong> Viant Technology Inc. is an advertising technology company with a market capitalization of approximately $741.88 million.</p><p><strong>Operations:</strong> Viant Technology generates revenue primarily through its Enterprise Technology Platform, which contributed $324.13 million. The company focuses on providing advertising technology solutions to its clients.</p><p>Viant Technology's strategic moves, including a notable integration with iHeartMedia and partnerships like the one with Molson Coors, underscore its commitment to enhancing programmatic advertising and outcome-driven strategies. This is evident from its 13.3% annual revenue growth and robust earnings growth of 44.2% per year, outpacing the US market average. The company's recent third-quarter sales increase to $85.58 million from $79.92 million the previous year reflects a solid execution of its business model in a competitive tech landscape. Viant's focus on direct publisher relationships through initiatives like Direct Access further positions it as an innovator in connected TV (CTV) and digital advertising spaces, leveraging advanced technology to optimize ad spending efficiency and effectiveness.</p><ul><li>Click here and access our complete health analysis report to understand the dynamics of Viant Technology.</li><li>Learn about Viant Technology's  historical performance.</li></ul><figure><img height="476" src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/d76d5b3b-65f9-42ba-b2be-d5bd08db8e8d/chart/revenue-and-expenses-breakdown?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" width="746" original-src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/d76d5b3b-65f9-42ba-b2be-d5bd08db8e8d/chart/revenue-and-expenses-breakdown"/><figcaption>DSP Revenue and Expenses Breakdown as at Dec 2025</figcaption></figure><h2>Dynavax Technologies (DVAX)</h2><p><strong>Simply Wall St Growth Rating:</strong> ★★★★☆☆</p><p><strong>Overview:</strong> Dynavax Technologies Corporation is a commercial-stage biopharmaceutical company that specializes in developing and commercializing vaccines both in the United States and internationally, with a market cap of approximately $1.31 billion.</p><p><strong>Operations:</strong> Dynavax Technologies focuses on the discovery, development, and commercialization of novel vaccines, generating revenue of $330.51 million. The company operates in the biopharmaceutical sector with a primary emphasis on vaccine innovation and distribution both domestically and internationally.</p><p>Dynavax Technologies, amid a transformative phase, has shown robust financial and operational growth with its recent acquisition by Sanofi for $1.9 billion, signaling strong market confidence. This strategic move is complemented by a significant 52.76% forecast in annual earnings growth and an impressive jump in quarterly revenue from $80.63 million to $94.88 million year-over-year. The firm's commitment to innovation is evident from its R&amp;D initiatives like the Z-1018 shingles vaccine, which competes closely with established products, showcasing Dynavax's potential to impact public health significantly.</p><ul><li>Click here to discover the nuances of Dynavax Technologies with our detailed analytical health report.</li><li>Review our historical performance report to gain insights into Dynavax Technologies''s past performance.</li></ul><figure><img height="476" src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/ac20658d-f845-433c-9f57-6c7b056968ea/chart/revenue-and-expenses-breakdown?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" width="746" original-src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/ac20658d-f845-433c-9f57-6c7b056968ea/chart/revenue-and-expenses-breakdown"/><figcaption>DVAX Revenue and Expenses Breakdown as at Dec 2025</figcaption></figure><h2>Phreesia (PHR)</h2><p><strong>Simply Wall St Growth Rating:</strong> ★★★★☆☆</p><p><strong>Overview:</strong> Phreesia, Inc. offers an integrated SaaS-based software and payment platform tailored for the healthcare industry across the United States and Canada, with a market cap of approximately $992.93 million.</p><p><strong>Operations:</strong> Phreesia generates revenue primarily from its Technology Solutions segment, which accounted for $463.21 million.</p><p>Phreesia has demonstrated a notable turnaround, transitioning from a net loss of $14.4 million to a net income of $4.27 million in its recent quarterly report, reflecting significant operational improvements and effective cost management. This shift is underscored by an impressive 10.7% annual revenue growth, positioning the company well within the competitive tech landscape. Further bolstering investor confidence, Phreesia has raised its fiscal 2026 revenue forecast to between $479 million and $481 million, indicative of sustained growth momentum and strategic business expansions such as the AccessOne integration expected to contribute an additional $7.5 million in revenue. This proactive approach in forecasting and adapting to market demands suggests promising prospects for Phreesia's continued expansion in high-tech solutions.</p><ul><li>Click to explore a detailed breakdown of our findings in Phreesia's health report.</li><li>Assess Phreesia's past performance with our detailed historical performance reports.</li></ul><figure><img height="476" src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/966203ed-2bd1-4229-9f79-b4030f1b40d5/chart/revenue-and-expenses-breakdown?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" width="746" original-src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/966203ed-2bd1-4229-9f79-b4030f1b40d5/chart/revenue-and-expenses-breakdown"/><figcaption>PHR Revenue and Expenses Breakdown as at Dec 2025</figcaption></figure><h2>Make It Happen</h2><ul><li>Gain an insight into the universe of 73 US High Growth Tech and AI Stocks by clicking here.</li><li>Invested in any of these stocks? Simplify your portfolio management with Simply Wall St and stay ahead with our alerts for any critical updates on your stocks.</li><li>Discover a world of investment opportunities with Simply Wall St's free app and access unparalleled stock analysis across all markets.</li></ul><h2>Ready For A Different Approach?</h2><ul><li>Explore high-performing small cap companies that haven't yet garnered significant analyst attention.</li><li>Fuel your portfolio with companies showing strong growth potential, backed by optimistic outlooks both from analysts and management.</li><li>Find companies with promising cash flow potential yet trading below their fair value.</li></ul> <p><em> This article by Simply Wall St is general in nature. <strong>We provide commentary based on historical data      and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice.</strong> It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your      financial situation. We aim to bring you long-term focused analysis driven by fundamental data.      Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material.      Simply Wall St has no position in any stocks mentioned.</em></p><div><p>Mobile Infrastructure for Defense and Disaster</p><p>The next wave in robotics isn't humanoid. Its fully autonomous towers delivering 5G, ISR, and radar in under 30 minutes, anywhere.</p><p>Get the investor briefing before the next round of contracts</p><p><span>Sponsored On Behalf of CiTech</span></p></div></div></div>

PLTR

<p>The U.S. stock market is reaching new highs, with tech stocks leading gains. Investors are eyeing high-growth sectors for opportunities. Top tech companies like Marker Therapeutics, Palantir, and Workday show significant revenue and earnings growth. Viant Technology, Dynavax Technologies, and Phreesia are highlighted for their strategic moves and financial growth. Viant focuses on advertising tech, Dynavax on vaccines, and Phreesia on healthcare software. The article encourages exploring 73 high-growth tech and AI stocks for potential investment opportunities.</p>

- The U.S. stock market has reached new highs, with the S&P 500 driven by tech stocks, prompting investors to seek opportunities in high-growth sectors.  
- Notable companies identified include Viant Technology, Dynavax Technologies, and Phreesia, each showing strong revenue and earnings growth.  
- These firms are innovating in their respective fields, signaling potential for significant impact on their industries amidst evolving economic conditions.

Exploring US High Growth Tech Stocks for Potential Expansion